New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 31, 2012
12:34 EDTBMY, PFE, DUF, CG, HLF, CALMOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday as the last minute fiscal cliff negotiations may prove to be a boost, or a bane, to the averages in the last hours of trading of the year. With little else for investors to key in on, the fiscal cliff headlines will dominate once again for the remainder of the session... ECONOMIC EVENTS: In the U.S. a minor economic report, the Dallas Fed's December manufacturing survey, came in better than expected at +6.8. In China, the HSBC purchasing managers’ index for December rose to a final reading of 51.5, an upward revision from the preliminary 50.9 result and an improvement from 50.5 a month earlier... COMPANY NEWS: After Friday's closing bell, the FDA announced it had approved the anti-clotting drug Eliquis, marketed by Bristol-Myers Squibb (BMY) and Pfizer (PFE). Atlantic Equities upgraded Bristol-Myers citing the approval and shares advanced about 1%. Pfizer shares, however, slid about 0.3%... MAJOR MOVERS: Among the notable gainers was Duff & Phelps (DUF), up 20% after agreeing to be acquired by a group led by The Carlyle Group (CG), with the provision that Duff & Phelps can continue to seek a better deal. Also higher were shares of Herbalife (HLF), which rose over 8% as the stock continues to bounce back from the sell-off begun with Bill Ackman's revelation of his short position. Among the noteworthy losers was Cal-Maine Foods (CALM), down 10% after reporting Q2 earnings that missed expectations... INDICES: Near noon, the Dow was down 2.10, or 0.02%, to 12,936.01; the Nasdaq was up 20.07, or 0.68%, to 2,980.38; and the S&P 500 was up 3.80, or 0.27%, to 1,406.23.
News For BMY;PFE;DUF;CG;HLF;CALM From The Last 14 Days
Check below for free stories on BMY;PFE;DUF;CG;HLF;CALM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 15, 2014
08:28 EDTCGCarlyle in talks to acquire up to 75% stake in India's Famy Care, Reuters says
Subscribe for More Information
07:27 EDTPFEIBC Life Sciences to hold a conference
Subscribe for More Information
07:27 EDTPFEPfizer acquisition could drive shares higher, says JPMorgan
Subscribe for More Information
September 14, 2014
16:17 EDTHLFHerbalife near settlement with former distributors, NY Post says
Herbalife is close to reaching a settlement with five former distributors that allege the nutrition company is a pyramid scheme and has victimized thousands, says the NY Post. Reference Link
13:32 EDTPFEPfizer shares look cheap, Barron's says
Subscribe for More Information
September 12, 2014
16:46 EDTCALMCal-Maine Foods announces joint venture acquisition of Egg-Land Best
Cal-Maine Foods announced that Southwest Specialty Eggs, LLC, the company’s joint venture with Hickman’s Egg Ranch, Inc., has acquired the Egg-Land’s Best, Inc. franchise for the southern California markets, including Clark County and Las Vegas, Nevada. As a result of this transaction, Southwest Specialty Eggs, LLC, will have licensing agreements for the sale of Egg-Land’s Best and Land O’ Lakes branded specialty eggs, as well as 4Grain, Farmhouse Eggs and other premium brands in this market region. Sales of Egg-Land’s Best specialty eggs accounted for approximately 14.4% of Cal-Maine’s total shell egg sales in FY14.
10:32 EDTPFEPfizer CEO says company still open to inversion deal, FT says
Pfizer (PFE) CEO Ian Read said U.S. rhetoric against tax inversions has been "political theater" ahead of midterm elections and made clear that his company is still open to a potential tax-saving acquisition, according to Financial Times, which added Read's comment about not being “held hostage” over price would likely be read as a signal the company might look elsewhere after being rebuffed by AstraZeneca (AZN). The Fly notes that Bloomberg previously reported, citing people familiar with the matter, that Pfizer is looking at targets other than AstraZeneca, including Actavis (ACT). Shares of Actavis trading in New York are up 2% this morning. Reference Link
09:31 EDTCALMCal-Maine Foods upgraded to Buy from Neutral at Sidoti
Subscribe for More Information
September 11, 2014
19:53 EDTCGCCMP Capital to acquire stake in PQ Corporation from The Carlyle Group
Subscribe for More Information
September 8, 2014
07:15 EDTPFEIBC Life Sciences to hold a conference
10th Annual Cell Line Development & Engineering Conference to be held in Berkeley, California on September 8-10.
06:00 EDTCGCarlyle Group closes Carlyle Asia Partners IV fund
Carlyle Group announced the final close of Carlyle Asia Partners IV at $3.9B, more than 50% larger than its predecessor fund CAP III. Carlyle’s Asia buyout funds make control and significant minority investments in well established companies across the Asia ex-Japan region. The final close of CAP IV, which exceeded its target of $3.5B, brings the firm’s assets under management in Asia funds, including Japan, to $13.6B across its buyout, growth, RMB and real estate funds. Reference Link
September 5, 2014
16:45 EDTBMYMarket ends week little changed after mixed economic data
Subscribe for More Information
11:17 EDTBMYBristol-Myers files patent infringement suit against Merck
Subscribe for More Information
09:10 EDTHLFHerbalife distributor claims fired for web sales, Seeking Alpha contributor says
Subscribe for More Information
September 4, 2014
16:05 EDTPFEPfizer granted orphan status for sickle cell disease drug
Subscribe for More Information
13:56 EDTCGGetty Images files lawsuit against Microsoft over photo tool, Reuters reports
Subscribe for More Information
08:02 EDTBMYTeva launches generic Baraclude in U.S.
Teva (TEVA) announces the launch of the generic equivalent to Baraclude tablets in the U.S. Teva was first to file, making the product eligible for 180 days of marketing exclusivity. Baraclude is marketed by Bristol-Myers Squibb (BMY).
07:23 EDTPFEAstraZeneca called for inversion clamp down as part of defense, WSJ says
Amid its defense against an unsolicited takeover bid from rival Pfizer (PFE), AstraZeneca (AZN) hired advisers with close ties to the Obama administration, who made calls to senior administration officials urging a clamp down on tax inversions, said The Wall Street Journal, citing people familiar with the previously undisclosed calls. Reference Link
September 3, 2014
11:30 EDTPFEPfizer has conference call hosted by Bernstein
Subscribe for More Information
06:35 EDTCGJPMorgan in talks to sell oil-supply agreement to Bank of America, WSJ says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use